𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations in hepatitis C virus NS3 protease domain associated with resistance to specific protease inhibitors in antiviral therapy naïve patients

✍ Scribed by Allan Peres-da-Silva; Adilson José de Almeida; Elisabeth Lampe

Publisher
Springer Vienna
Year
2010
Tongue
English
Weight
458 KB
Volume
155
Category
Article
ISSN
1432-8798

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Naturally occurring dominant resistance
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
✍ Thomas Kuntzen; Joerg Timm; Andrew Berical; Niall Lennon; Aaron M. Berlin; Sarah 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

Resistance mutations to hepatitis C virus (HCV) nonstructural protein 3 (NS3) protease inhibitors in <1% of the viral quasispecies may still allow >1000-fold viral load reductions upon treatment, consistent with their reported reduced replicative fitness in vitro. Recently, however, an R155K proteas

Mutations associated with lamivudine-res
Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: Implications for antiretroviral therapy in HBV and HIV co-infected South African patients
✍ S. Gloria Selabe; Azwidowi Lukhwareni; Ernest Song; Yeegan G.M. Leeuw; Rosemary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract This was an exploratory study to investigate lamivudine‐resistant hepatitis B virus (HBV) strains in selected lamivudine‐naïve HBV carriers with and without human immunodeficiency virus (HIV) co‐infection in South African patients. Thirty‐five lamivudine‐naïve HBV infected patients with